Seasonal influenza vaccine could reduce cardiovascular events in type 2 diabetes patients

被引：0
|
作者：
不详
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2016年 / 12卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：2216 / 2216
页数：1
相关论文
共 50 条
  • [21] Clinical cardiovascular phenotypes and the pattern of future events in patients with type 2 diabetes
    Mariam Elmegaard Malik
    Charlotte Andersson
    Paul Blanche
    Maria D’Souza
    Christian Madelaire
    Bochra Zareini
    Morten Lamberts
    Søren Lund Kristensen
    Naveed Sattar
    John McMurray
    Lars Køber
    Christian Torp-Pedersen
    Gunnar Gislason
    Morten Schou
    Clinical Research in Cardiology, 2023, 112 : 215 - 226
  • [22] Increased risk of cardiovascular events among type 2 diabetes patients with dyslipidemia
    Blonde, Lawrence
    Fox, Kathleen M.
    Ohsfeldt, Robert L.
    Parikh, Shamik
    Grandy, Susan
    CIRCULATION, 2007, 115 (08) : E230 - E230
  • [23] New evidence on the prevention of cardiovascular events in hypertensive patients with type 2 diabetes
    Pahor, M
    Psaty, BM
    Furberg, CD
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 : S18 - S23
  • [24] What is the effect of fenofibrate on cardiovascular disease events in patients with type 2 diabetes?
    Mazzone, T.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (07): : 366 - 367
  • [25] Characterization and cholesterol management in patients with cardiovascular events and/or type 2 diabetes in the Netherlands
    Heintjes, Edith
    Kuiper, Josephina
    Lucius, Bianca
    Penning-van Beest, Fernie
    Kutikova, Lucie
    Liem, Anho
    Herings, Ron
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (01) : 91 - 100
  • [26] Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus
    Song, Do Kyeong
    Hong, Young Sun
    Sung, Yeon-Ah
    Lee, Hyejin
    PLOS ONE, 2024, 19 (02):
  • [27] Relationship of thyroid hormone levels and cardiovascular events in patients with type 2 diabetes
    Moura Neto, A.
    Parisi, M. C. R.
    Tambascia, M. A.
    Pavin, E. J.
    Alegre, S. M.
    Zantut-Wittmann, D. E.
    ENDOCRINE, 2014, 45 (01) : 84 - 91
  • [28] Adiponectin and atherosclerosis related cardiovascular events in type 2 diabetes dialysis patients
    Kacso, I. M.
    Potra, A. R.
    Bondor, C. I.
    Moldovan, D.
    Rusu, C.
    Patiu, I. M.
    Racasan, S.
    Orasan, R.
    Vladutiu, D.
    Spanu, C.
    Rusu, A.
    Nita, C.
    Moldovan, R.
    Ghigolea, B.
    Kacso, G.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2015, 45 : 90 - 90
  • [29] LDL-CHOLESTEROL AND CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES MELLITUS TYPE 2
    Tudor, C.
    Iana, A.
    Jeberean, R. A.
    Petrus, A.
    Buzas, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 33 - 34
  • [30] What is the effect of fenofibrate on cardiovascular disease events in patients with type 2 diabetes?
    Theodore Mazzone
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 366 - 367
12345